Spontaneous conversion from e antigen to e antibody (a change known as seroconversion) is a predictor of long-term clearance of HBV in patients undergoing antiviral therapy and indicates lower levels of HBV and therefore lower infectivity.

In hepatitis B virus (HBV) carriers and in patients with chronic hepatitis B, positive anti-HBe results usually indicate inactivity of the virus and low infectivity of the patients. Positive anti-HBe results in the presence of detectable HBV DNA in serum indicate active viral replication.

The Anti-HBe test, also called HBeAb, is used to detect antibodies that target the HBeAg antigen. These antibodies play a key role in suppressing the replication of the hepatitis B virus (HBV), including mutated strains, within the body.

The presence of antibody to hepatitis Be antigen (anti-HBe) can be used in conjunction with other serological and clinical information to determine the stage and prognosis of hepatitis B infection.

Mar 1, 2019 · During recovery from acute hepatitis B, HBeAg becomes undetectable in the serum, while antibodies to HBeAg (anti-HBe) become detectable. Anti-HBe usually remain detectable for years after...

Presence of hepatitis B virus e antigen (HBeAg) and absence of HBe antibody (anti-HBe) usually indicate active hepatitis B virus (HBV) replication and high infectivity. Absence of HBeAg with appearance of anti-HBe is consistent with loss of HBV infectivity.

Chronic hepatitis B can be divided into e antigen- (HBeAg) positive or HBeAg-negative disease based on the presence or absence of e antigen. The presence of HBeAg is typically associated with higher rates of viral replication and therefore increased infectivity.

anti-HBe or HBeAb (Hepatitis B e-Antibody) - This is not a protective antibody. It is made in response to the hepatitis B e-antigen. Chronically infected individuals who stop producing e-antigen sometimes produce e-antibodies.

Antibody to HBeAg (anti-HBe) can be found in both acute and chronic infection; its presence usually is accompanied by decreased viral load and decreased infectivity (Table 213.1). HBV DNA is a marker of virus replication.

Oct 29, 2021 · HBeAg seroconversion is the development of antibodies against HBeAg (anti-HBe); it marks a transition from active disease to an inactive ‘carrier’ state. 5 Anti-HBe remains in serum for life and indicates acquired, natural immunity (i.e. immunity from a …